What Makes a WHO-cGMP Certified Pharma Manufacturer Stand Out in India

June 3, 2025

WHO-cGMP (World Health Organization – current Good Manufacturing Practices) certification shows that a pharmaceutical company meets international quality standards. In India, this certification sets manufacturers apart. India is already known as the “pharmacy of the world” because it supplies around 20% of global pharmaceutical needs. A big part of this success is due to companies that follow WHO-cGMP standards.

United Biotech India Pvt. Ltd., a key player in the Indian pharmaceutical industry, also holds WHO-cGMP certification and upholds strict manufacturing practices, ensuring high-quality medicines that meet international standards.

Why WHO-cGMP Certification Matters

WHO-cGMP certified facilities follow strict rules for how medicines are made, stored, tested, and shipped. This ensures the medicines are:

  • Safe to use
  • Effective
  • Of consistent quality

These practices also build trust worldwide, especially in regulated markets like the U.S., Europe, and the Middle East.

Main Benefits of WHO-cGMP Certification:

  • Export Advantage – Companies with this certification can export medicines more easily.
  • High Formulation Quality – Medicines are made under clean and controlled environments.
  • Global Reputation – Builds trust among international buyers and regulatory bodies.
  • Fewer Compliance Issues – Reduces chances of product recalls and bans.

Strong Infrastructure for Exports

India’s pharmaceutical exports reached $27.9 billion in FY2024, and WHO-cGMP certified companies like United Biotech India Pvt. Ltd. are major contributors. These companies:

  • Export to more than 200 countries
  • Offer affordable yet high-quality generic medicines
  • Comply with packaging and shipping standards for global markets

WHO-cGMP certification also helps in:

  • Faster customs clearance
  • Access to government tenders
  • Partnerships with global health agencies like WHO and UNICEF

Focus on Quality and Compliance

Indian manufacturers now follow upgraded standards under Schedule M (revised in December 2023), which match WHO-cGMP guidelines. This update encourages:

  • Use of electronic records
  • Modern equipment and processes
  • Cleaner and safer work environments

United Biotech India Pvt. Ltd. and similar companies follow these best practices to ensure continuous quality improvement and safety.

Key Compliance Highlights:

  • Certified quality systems and regular audits
  • Cleanrooms and automated production lines
  • In-house labs for strict testing
  • Updated training for all staff

These efforts reduce the risk of medicine shortages or export bans and help Indian companies maintain a good global reputation.

Building Global Trust

India is trusted by global health organizations because of its commitment to WHO-cGMP standards. Companies that follow these rules are seen as reliable partners.

United Biotech India Pvt. Ltd., for example, focuses on maintaining strong relationships with global clients by offering:

  • Consistent quality
  • Competitive pricing
  • Timely deliveries

Indian companies now supply:

  • 50% of global vaccine demand
  • Over 20% of global generic medicines

This scale is only possible because of the high trust built through certifications like WHO-cGMP.

Leave a Comment